Kennedy PhRMA-Friendly Agenda Includes Wariness Of Waxman/Hatch Reform

Waxman/Hatch reform should not be undertaken without setting clear boundaries, Sen. Kennedy (D-Mass.) told the Pharmaceutical Research & Manufacturers of America annual meeting in Naples, Fla., March 31.